Microbot Medical (NASDAQ:MBOT) Price Target Raised to $9.00 at HC Wainwright

Microbot Medical (NASDAQ:MBOT) had its target price hoisted by HC Wainwright from $7.00 to $9.00 in a report released on Friday,Benzinga reports. The firm currently has a buy rating on the biotechnology company’s stock.

Microbot Medical Stock Up 6.3 %

Shares of NASDAQ:MBOT opened at $2.03 on Friday. Microbot Medical has a fifty-two week low of $0.82 and a fifty-two week high of $3.38. The firm’s 50 day moving average price is $1.29 and its 200 day moving average price is $1.08.

About Microbot Medical

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.